cncpt-artikel_lb_atf
WCLC 2023 – NSCLC: New Data on Perioperative Immunotherapy Treatment
Can perioperative treatment with Imfinzi in combination with chemotherapy improve the pathological complete response (pCR) and increase event-free survival (EFS) in patients with resectable NSCLC with a positive PD-L1 status?